å»è¬åå ¬è¡šãããæŽå¯
MDSã®myelodysplasticçå矀(MDS)ãšãã®æ©æèšºæããã³MDSã®æ°ããæ²»çãªãã·ã§ã³ã®å¯çšæ§ã«é¢ããå ¬çãªæèãé«ããããšã¯ãäºæž¬æéã«ããã£ãŠåžå Žã®æé·ãä¿é²ããããšãæåŸ ãããŠããŸãã ãŸããæ©ææ²»çã§æ£è ã®ç掻ã®è³ªãèããå¢å ããããããMDSã®æ©æèšºæãéèŠã§ãããŸããåçºè¡æ¶²ã®èŒžè¡ã®å¯èœæ§ãäœäžãããããæ·±å»ãªçäŸã§ã30%ã®æç¹ã§ã¯ãMDSçŸæ£ã®çœè¡çã®é²åãçŠæ¢ããããšãã§ããŸãã æ¿åºæ©é¢ãå»è¬å補é äŒç€ŸããMDSã®æ®ååçºã«æ³šåããè³é調éã»åçºããã°ã©ã ã宿œããŠããŸãã ããšãã°ã2018幎10æã«ã¯ãã©ãã³ã¢ã¡ãªã«ã®Grupo Biotoscana(ã¢... ãã£ãšèŠã
æ é€ã¯ãå¥åº·ãç¶æããããŸããŸãªç æ°ãäºé²ããããã«å¿ èŠãªæãéèŠãªèŠçŽ ã®äžã€ã§ãã æ é€è£å©ã¯ãé£äºãéããŠååãªæ é€å€±èª¿ãåŸãããšãã§ããªã人ã ã«äžããããŸãã è žæ é€ããã¥ãŒãäŸçµŠãšãåŒã°ããè žæ é€ã¯ãéåžžã®çµå£é£äºãæ¶²äœã®ãµããªã¡ã³ããå«ãã«ããªãŒã®èŠä»¶ããèè ž(GI)ã®ãã©ã¯ã¿ãŒã䜿çšããçµŠé€æ¹æ³ãæããŸãããŸãã錻ãéããŠæäŸãããæ é€çŽ ã¯ã錻氎管ã錻ãéã£ãŠèã«å ¥ãããã錻åœé æ é€çæ³ãšåŒã°ãã錻氎管ã¯ç®èãéã£ãŠçŽæ¥é 眮ãããŸãã ãã®åŒã¯ãå¿ èŠãªæ é€ãšè¬ãåŸãããã«æ©ç£ä¹³å ãå©ããŸãã åºç£çŽåŸã«æé£ããããã«ã第32é±ãšç¬¬34é±åã«çãŸããåäŸã¯ãåãæ°ç®¡ãåãåãå¿ èŠãã... ãã£ãšèŠã
å ç«æ¬ ä¹çã¯ã身äœã®å ç«ã·ã¹ãã ããŠã€ã«ã¹ã现èãçèãå¯çè«ãªã©ã®ããŸããŸãªç åäœããä¿è·ãæäŸãã宿çãªæ©èœãå®è¡ããªãã£ããšãã«åŒãèµ·ããããŸãã ãããã®å ç«äžå šçŸæ£ã¯ãç¬¬äžæ¬¡ããã³äºæ¬¡å ç«äžå šçŸæ£ã«åé¡ããããšãã§ããŸãã ç¬¬äžæ¬¡å ç«äžå šçŸæ£ã¯ãåºçæã«å人ã«ååšããéºäŒåã®åé€ãéºäŒåã®éè€ãªã©ã®éºäŒåå€ç°ã®çµæã§ããã ãããã®éºäŒçæ¬ é¥ã¯ãçµåå ç«æ¬ ä¹ççŸæ£ãDiGeorgeçå矀ãhypogammaglobulinemiaããã«ãŒãã³ç ãªã©ã®äž»èŠãªå ç«äžå šçŸæ£ã«ã€ãªããå¯èœæ§ããããŸãã äºæ¬¡å ç«äžå šæ§çŸæ£ã®åå ãšãªãèŠå ã®äžéšã«ã¯ãæ é€ãç³å°¿ç ãæŸå°ç·ãé床ã®ç«å·ãªã©ãã... ãã£ãšèŠã
Prurigoã®nodularisã¯ç®ã®æãã®ãã£ããããå¡ã«ãã£ãŠç¹åŸŽä»ããããç®ã®ç¶æ ã§ãã 20ã60æ³(ç·å¥³)ã®å€§äººãäžå¿ã«ãå šãŠã®å¹Žéœ¢ã®äººã ã«åœ±é¿ãäžããŸãã ããã¯éæ¬ ä¹è²§è¡ãæ ¢æ§è äžå šãã°ã«ãã³è žçãHIVææãªã©ã®ç æ°ã«é¢é£ä»ããããŠããŸããããã®ç®èã®ç¶æ ã®å®éã®åå ã¯äžæã§ãããã®ãããªç®èææçã®çºççã¯ãäºæž¬æéäžã®åžå Žæé·ãä¿é²ããããšãæåŸ ãããŸãã äŸãã°, ç®èç§åŠã®ã¢ã¡ãªã«ã®ã¢ã«ãããŒã®ãžã£ãŒãã«ã«ãããš (JAAD) 2020, Prurigo nodularisã®æå¹æéã¯ã 36.7 å®å 43.9 ç±³åœã§100,000ã®äººå£ããã.äžçã®ãã«ãªãŽã®ãã... ãã£ãšèŠã
Liposomal doxorubicinã¯ãAIDSé¢é£ã®Kaposiã®ãµã«ããbreastçãåµå·£çããã³ä»ã®åºäœè «çãæ²»çããããã«éèçã«æäžãããååŠçæ³è¬ã§ãã Liposomeã®è¬å€ã®é éã·ã¹ãã ã¯çްèã®ä»£çåºã®pharmacokineticsãããŠçç©é åãå€ããããšãã§ããŸããããã¯neoplasticãã£ãã·ã¥ã«è§£æŸãããè¬å€ã®éäžãé«ããè¬å€ãä»ããŠããæ£åžžãªãã£ãã·ã¥ã®é²åºãæžããããšãã§ããŸãã ãã®è¬ã¯ãããã·ã«ãšãããœã«ãã·ã³å¡©é žå¡©ãªããœãŒã ãšãåŒã°ããã¢ã³ãã©ãµã€ã¯ãªã³æè «çå€ã®äžçš®ã§ãã ãããœã«ãã·ã³å¡©é žå¡©ãªããœãŒã ã®æäžéã¯ã身é·ãšäœéãäžè¬çãªå¥åº·ãŸãã¯... ãã£ãšèŠã
Polycythemia veraã¯ã骚é«(é«å¢æ®)ã«ãããè¡æ¶²çްèã®éå°çæã䌎ããŸãã§æ ¢æ§çãªé害ã§ãã èµ€è¡çã®éå°çç£ã¯æãå€åããŠããŸãããçœè¡çãè¡å°æ¿ã®çç£ãã»ãšãã©ã®å ŽåäžæããŠããŸãã èµ€ãè¡çããããŒã«åŒãèµ·ããããã®ã§ãããã¯è¡æ¶²äžã®èµ€è¡çã埪ç°ãããç°åžžã«é«ãæ°ããããããŸãã ãã®çµæãè¡ãåããªããäœç©ãå¢å ããé«ç²åºŠãšåŒã°ããæ¡ä»¶ã æ¿åãªè¡æ¶²ã¯ãå°ããªè¡ç®¡ãæ£ããæµããªãå ŽåããããŸãã é çãç²åŽã匱ããããŸããããã¿ãªã©ã®éç¹ç°çãªçç¶ãå«ãå€å¢è¡çã®ãã©ãæã€å人ã§ããŸããŸãªçç¶ãèµ·ãããæ¡å€§ãããèŸè(ã¹ãã¬ã³ã²ãªãŒ)ãæ§ã ãªæ¶ååšã®åé¡ãšè¡æ¶²ååºã®å±éº... ãã£ãšèŠã
ç±³åœãšãã»ã³ã·ã£ã«ãªã€ã«ã«ãã»ã«åžå Žãã«ãã»ã«ã¿ã€ãå¥ïŒãããŒãã³ããªã€ã«ã«ãã»ã«ããã£ãŒããªãŒãªã€ã«ã«ãã»ã«ãã©ãã³ããŒãªã€ã«ã«ãã»ã«ããŠãŒã«ãªãªã€ã«ã«ãã»ã«ãã¬ã¢ã³ãªã€ã«ã«ãã»ã«ããã©ã³ãã³ã»ã³ã¹ãªã€ã«ã«ãã»ã«ããžã³ãžã£ãŒãªã€ã«ã«ãã»ã«ãã¿ãŒã¡ãªãã¯ãªã€ã«ã«ãã»ã«ãªã©ïŒãçšéå¥ïŒæ é€è£å©é£åãã¢ããã»ã©ããŒã«ãã»ã«ãçŒç管çãåŒåžåšå¥åº·ãµããŒããç¡ç ãšãŠã§ã«ãã¹ãªã©ïŒãæµéãã£ãã«å¥ (ãªã³ã©ã€ã³å°å£²æ¥è ãè¬å±ããã³ãã©ãã°ã¹ãã¢ãã¹ãŒããŒããŒã±ãã/ãã€ããŒããŒã±ãããå¥åº·ããã³å°éåºãããã³çŽè²©/MLM)... ãã£ãšèŠã
åç±³ããã³ãšãŒãããã®ãã¡ãŒã¹ãã¡ã«ãé åžå Žãè¬å€ã¯ã©ã¹å¥ïŒæç²Ÿç¥ç è¬ããããã³ãã³ãé»å®³è¬ãæããããè¬ãæãã€è¬ãªã©ïŒãçŸæ£é©å¿çå¥ïŒçµ±å倱調çãã¢ã¬ã«ã®ãŒãããŒãã³ãœã³ç ãçé çã倧ãã€ç æ§é害ïŒMDDïŒãªã©ïŒã幎霢局å¥ïŒå°å ç§ãæäººãè人ç ïŒãæµéãã£ãã«å¥ïŒç é¢ïŒ è¬å±ãå°å£²è¬å±ãããã³ãªã³ã©ã€ã³è¬å±)ãå°çå¥ (åç±³ããã³ãšãŒããã)... ãã£ãšèŠã
åçãã£ã¹ã¯çŸæ£ã¯ãè³ãã£ã¹ã¯ã®ç Žå£ã«ãã£ãŠåŒãèµ·ããããèæ€ç¶æ ã§ãã åçãã£ã¹ã¯ç ã®ããã«èгå¯ãããçç¶ã¯ãè¶³ã®çã¿ãæ©è¡ã®å°é£ã§ãã ãã®ç æ°ã¯èº«äœæ€æ»ãšèšºæããã Xç· ãŸãã¯ç£æ°å ±é³Žã€ã¡ãŒãžã³ã°(MRI)ã 倿§ãã£ã¹ã¯çŸæ£ã¯ãæãäžè¬çã«ã¯ãèã®äººå£ã§èŠãããæäººã®è °çãšéŠã®çã¿ãåŒãèµ·ãããŸãããç±³åœåçãã£ã¹ã¯çŸæ£æ²»çåžå Žã¯ãåšããæã£ãŠãããšæšå®ãããŸã 2.644 Mnã® 2021幎ã«åçãã£ã¹ã¯ç (DDD)ã«èŠããã§ããæ£è ã¯ãå±ç€ºããããšäºæ³ããã ã«ã°ã¬ ã«ã€ã㊠5.9% äºå ±æéäž (2021-2028).å³1.U.S.倿§ãã£ã¹ã¯çŸæ£æ²»çåžå Žã¯ãæ²»ç2021ã«... ãã£ãšèŠã
å»è¬ååžå Žã¯ãç³å°¿ç ããããå¿è¡ç®¡çŸæ£ãæ ¢æ§è èç ãªã©ã®çŸæ£ã®æ²»çã«äœ¿çšãããå»è¬åãç£çããäºæ¥äœ(çµç¹åãå¯äžã®ãã¬ãŒããŒããã³ããŒãããŒã·ãã)ã«ããå»è¬åããã³é¢é£ãµãŒãã¹ã®å£²äžé«ã§æ§æãããŠããŸãã å»è¬åã¯ãç æ°ã®æ²»çã«ãããŠãè¬çšç®çã®ããã«äœ¿çšãããè¬ã®äžçš®ã§ããããšãã§ããŸãã ãã®æ¥çã«ã¯ããã€ãªå»è¬åãå»è¬åã補é ããçµç¹ãäŒæ¥ãå«ãŸããŸãã 補è¬äŒç€Ÿã¯ãäžèšã«ç€ºãããã«ãããŸããŸãªç æ°ã®ããã®ã«ã¹ã¿ãã€ãºãããåã ã®æ²»çã®ããã®å»è¬åãæäŸããŠããŸãã å人åãããè¬ãå¥ååŒã°ãã 粟å¯å»åŠãæ£è ã®åã ã®ç¹åŸŽããã³éºäŒçæ§é ã«åŸã£ãŠå»åŠã®å¿é ãæäŸããããšãç®æããŠããŸ... ãã£ãšèŠã
è¬å€ã®æ··åã¯åã ã®æ£è ã®å¿ èŠæ§ã«åãããè¬å€ãäœæããããã«åæãçµåããæ··åãããããŸãã¯å€ããããã»ã¹ã§ãã é åã«ã¯ã2ã€ä»¥äžã®è¬ã®çµåãå«ãŸããŠãããæ··åè¬ã¯FDAæ¿èªãããŠããŸãããè¬å€ã¯FDAã®æ¿èªãããè¬å€ãšæ±ãããããšãã§ããªãæ£è ã®ããã«ããã®ãããªæ£è ã®ããã«æ··åããããããããŸãã ã¢ã¬ã«ã®ãŒå¯Ÿå¿ ç¹å®ã®ææã«ãããããªãã§äœãããã«è¬ãå¿ èŠ, ãŸãã¯é«éœ¢è ã®æ£è ãã¿ãã¬ãããã«ãã»ã«ã飲ã¿èŸŒãããšãã§ããªãåäŸãæ¶²äœã®æäžéã®åœ¢ã§è¬ãå¿ èŠãšãã. ç é¢ã蚺çæããã³ä»ã®ãã«ã¹ã±ã¢æœèšã®å°éå»ã¯ãFDAã®æ¿èªãããè¬å€ãããããæ±ãã®ã«å»åŠçã«é©ããªããšãæ£è ã«æã æ··åã... ãã£ãšèŠã
Ureaãµã€ã¯ã«é害(UCD)ã¯6ã€ã®çžç¶çæ¬ é¥ã®ã°ã«ãŒãã§ã é µçŽ å°¿çŽ çŽ°èã®å°¿çŽ çŽ°èãæ§æãã2ã€ã®ãã©ã³ã¹ããŒã¿ãŒã ãªã³ã»ããçç¶ã®å¹Žéœ¢ã¯ãUCDã®çš®é¡ã«ãã£ãŠç°ãªããŸãã UCDã¯ããã°ãã°èªçºåŸã®ç°åã«ããäžåŠã®æéäžã«çºçããŸãã å°¿çŽ ã®åšæé害ã®èšºæã¯ç°åžžãªæ°é³ä»£è¬ç©ããã³é«ãã¢ã³ã¢ãã«ã®ã¬ãã«ã®ããã«ç¹æ€ããããã«å°¿ããã³è¡ã®åæã«ãã£ãŠè¡ãããŸãã å°¿çŽ ã®åšæã®ç¡ç§©åºã®æ£è ã®ã¢ã³ã¢ãã« ã¬ãã«ãç£å¯ããããã«é »ç¹ã«è¡ãã¹ãã¯è¡ãããŸãã å°¿çŽ ãµã€ã¯ã«éå®³ã®æ²»çã¯ãã¢ã³ã¢ãã¢ç£çãå¶éããããã«ãæ é€ç®¡çã§æ§æãããŠããŸãã èç§»æ€ã¯ãå°¿çŽ ãµã€ã¯ã«ã®é©åãªæ©èœã®ããã®å°¿çŽ ãµã€... ãã£ãšèŠã
ãã«ã¢ã³é¿åŠè¬ã«ã¯ããšã¹ããã²ã³ã®æç¡ã«ããããããããã²ã¹ãã³(ããã²ã¹ããã³è¬)ãå«ãŸããŠããŸãã ããã²ã¹ãã³ããã³ãšã¹ããã²ã³ã¯å®éšå®€ã§è£œé ããããã¹ãŠã®å¥³æ§ã«ãã£ãŠèªç¶ã«äœãåºããããã«ã¢ã³ã«é¡äŒŒããŠããŸãã ãããã®2ã€ã®ãã«ã¢ã³ã¯ãæåµãé²ã(åµã®æŸåº)ãåå®®ã®åšãã®ç²æ¶²(åå®®ã®å£)ãåããã粟åãåå®®(åå®®)ã«å ¥ãã®ãé²ãããŸãã¯ãããã¯åå®®ã®å åŽã®å£ãèãããå粟åµã®æ·»ä»ãé²ããããããŸããŸãªæ¹æ³ã§åŠåš ã鲿¢ããããã«ãåç¬ã§äœ¿çšãããŸããäžççãªãã«ã¢ã³é¿åŠè¬ã®åžå Žã¯ã2021幎ã®US $ 15,232.2ããªãªã³ãšæšå®ããã2028幎ãŸã§US $ 18,577.6çŸäžã«é... ãã£ãšèŠã
çµå£ç²èçã¯ã人äœã«ããã€ãã®åé¡ãåŒãèµ·ããå¯èœæ§ãããæ¶å管ã®ççã§ãã ããã¯äººã®äžè¬çãªæ 逿åéã«åœ±é¿ãäžããããšãã§ããŸãã å£è ç²èçã¯çæ²»çãä»ã®èŠå ããçããäžè¬çãªå¥åº·åé¡ã§ãã çã¿ãæ é€ã®åé¡ãå«ãããã€ãã®åé¡ã¯ãé£ã¹ãããšãã§ããªãåå ãšããŠçºçããç²èã®çã¿ã®å¢å€§ã«ããææã®ãªã¹ã¯ãå¢å ããŸããç±³åœã®é床ã®çµå£ç²èçåžå Žã¯ã US$ 78.5 ã¡ãŒãã« ãåãåãã 2021幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠19.2%(çšæ) äºå ±æéäž (2021-2028).å³1.U.S.é床ã®çµå£ç²èç 2021幎 å»è¬åã®çš®é¡ã«ãã䟡å€ã®èгç¹ããåžå Žã·ã§ã¢(%)ç±³åœã«ããã... ãã£ãšèŠã
æååºå€çæ³ãåºè¡ã®åé¡ã«ããé転ãŸãã¯äžåããå¿ èŠããããšããæååºå€çæ³ã®éå°æåããŸãã¯äºæããªãæè¡ãæååºå€é転è¬ãå¿ èŠã§ãã æååºå€é転ã¯ãæååºå€ãæçšããŠããæ£è ã®æ²»çã«éèŠãªã¹ãããã§ãããçåœãè ããåºè¡ãçµéšããŠããŸãã å»åž«ãæšå¥šããé転è¬ã¯ãæ£è ã®éžæè¢ã®æååºå€ã«ãã£ãŠæ±ºå®ãããŸãã çŽæ¥çµå£æååºå€(DOACs)ã¯ãdigatran etexilateãçŽæ¥ããã³ãã³é»å®³å€ãããã³åºæ¿ãããååºå åX(apixabanãbetrixabanãedoxabanãããã³rivaroxaban)ã®ç¹å®ã®é»å®³å€ã§æ§æãããŸãã DOACã¯ãã¯ãŒãã¡ãªã³ãšæ¯èŒããŠã¡ã€ã³ã... ãã£ãšèŠã
çèæ§è³ç externa ã¯ãå€éšè³ç®¡ã®çç(èµ€ã¿ããã³è «ã)ãåŒãèµ·ããç¶æ ã§ãã çèæ§è³çã®externaã¯æ°Žãžã®ç¹°ãè¿ãããé²åºãè³ãççã«ããè匱ã«ãããããšãã§ããã®ã§ããã°ãã°ã¹ã€ããŒã®è³ãšåŒã°ããŸãã æãäžè¬çãªç åäœã¯ãAspergillus(çäŸã®80ã90%)ã§ãã«ã³ãžããç¶ããŸãã çèææçã¯ãè³ã®éæ²³ã®ãããŒã©ã倿ŽããçŽ°èæ§è³éŒ»åœåç§ã®é·ææ²»çã®çµæã§ããäžççãªçèæ§è³çã®externaã®åžå Žã¯è©äŸ¡ããããšæšå®ãããŸã US$ 169.40 çŸäž ãåãåãã 2021幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠2.9% äºæž¬æéãè¶ ã㊠(2021-2028).ããã... ãã£ãšèŠã
ããäžç®æé·å å(EGF)ã¯ãå容äœEGFRã«çµåãã现è墿®ããã³å¢æ®ã«é¢äžããéºäŒåçµè·¯ã掻æ§åããããã®åå¿ã®éãéå§ããããªããããã§ãã çµæãã®äººéã®äžç®æé·å å(rhEGF)ã¯çްèãæ€ç©ããã³ä»ã®ãããªprokaryoticçç©ã·ã¹ãã ã§è¡šçŸãããŸãã çµæãã®äººéEGFã¯ãã¹ãã£ãŒãã³ã¹ã»ãžã§ã³ãœã³çå矀ãç³å°¿ç æ§è¶³æœ°çãé ç®ãå¯å ·ãªã©ã®æ¥æ§ããã³æ ¢æ§å·ã®æ²»çã«å¹æçã«äœ¿çšããããšãã§ããŸãã rhEGFã¯ãŸãç®ã®è³ªã®æ¹è¯ã®ããã®åç²§åã®äŒæ¥ã®äœ¿çšããæžããããã«èŠã€ããŸã ã¹ã«ãŒã¯ 圢æããã³hyperpigmentationãçãæžããããã å ããŠãrhEGFã¯ãçäœå·¥åŠ... ãã£ãšèŠã
Mucormycosis (äž»ã«zygomycosisãšããŠåŒã°ãã)ã¯mucormycetesãšåŒã°ããåã®ã°ã«ãŒãã«ãã£ãŠåŒãèµ·ããããæ·±å»ãªããŸããªçèææçã§ãã ãŸãã空æ°ããçèèåãåžããšãèºãå¯éŒ»è ã«åœ±é¿ãäžããããšãã§ããŸãã çèã¯ãŸããã«ãããã¹ã¯ã¬ãŒããããŒã³ããŸãã¯ç®èå€å·ãªã©ã®å·ãéããŠç®èãäŸµå ¥ããŸãã çèææçã¯èª°ã«ã圱é¿ãåãŒãå¯èœæ§ããããŸããã匱äœåããå ç«ã·ã¹ãã ãæã€äººã ã®äžã§æãäžè¬çã§ãããäœã®ã»ãŒãã¹ãŠã®éšåã§èµ·ããããã ç²èçãçºçãããªã¹ã¯èŠå ã¯ãå¶åŸ¡ãããŠããªãç³å°¿ç ãçã èåšç§»æ€ãneutropeniaã®ç®ã®traumaã Muco... ãã£ãšèŠã